| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/10/2004 | CN1141136C Chinese medicine injection for treating acute cerebral hemorrhage and preparation method thereof |
| 03/10/2004 | CN1141121C Medicine for clinical first and treatment of hematencephalon and its prepn method |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6703046 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004018491A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004017971A1 Use of a papaverine-like vasodilator and pharmaceutical composition |
| 03/04/2004 | WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain |
| 03/04/2004 | WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
| 03/04/2004 | WO2004017950A2 Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003080104A3 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 03/04/2004 | WO2003065871A3 Methods and compositions for treating hematological disorders |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003019198A3 Methods relating to treatment of atherosclerosis |
| 03/04/2004 | WO2003019196A3 Diagnosis and treatment of atherosclerosis |
| 03/04/2004 | WO2003016348A3 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 03/04/2004 | WO2002098856A3 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002094197A3 Bicyclic inhibitors of factor xa |
| 03/04/2004 | WO2002089675A9 Wound closure system and methods |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | US20040044272 Personal condition management system |
| 03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/04/2004 | US20040044204 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044021 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043933 Mixture with pH moderator, antioxidant and Group 2a salt; anticoagulant |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043454 Growth arrest homeobox gene |
| 03/04/2004 | US20040043076 Containing protein active material; solvent-free |
| 03/04/2004 | US20040043008 Dissociation muscle tissues; culturing; accumulation |
| 03/04/2004 | DE10261126A1 Lagerungsstabile, flüssige Fibrinogen-Formulierung Storage stable liquid fibrinogen formulation |
| 03/04/2004 | CA2493328A1 Use of a papaverine-like vasodilator and pharmaceutical composition |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1393741A1 Storage-stable, liquid fibrinogen-formulation |
| 03/03/2004 | EP1393723A2 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392816A1 Production of bioavailable folic acid |
| 03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392375A2 Composition and use of substances for stabilising amino acids containing sulphur |
| 03/03/2004 | EP1392345A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392309A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1392272A1 Permeation enhancers |
| 03/03/2004 | EP1392133A2 Functional agent for decomposing nicotine and method of preparing the same |
| 03/03/2004 | EP1196440B1 Therapeutic peptides derived from subsequences of bpi |
| 03/03/2004 | EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 03/03/2004 | EP1109571B1 Methods of treating salt-dependent hypertension |
| 03/03/2004 | EP1062224A4 Modified factor viii |
| 03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
| 03/03/2004 | EP0859628B9 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
| 03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
| 03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
| 03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
| 03/03/2004 | CN1479722A Guanidine and amidine derivatives as factor Xa inhibitors |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
| 03/03/2004 | CN1478536A Proprietury Chinese medicine for stopping blood, analgesia, removing blood stasis and engender new and its preparation method |
| 03/03/2004 | CN1478504A Chinese herbal medicine for treating aplastic anemia |
| 03/03/2004 | CN1140536C Minotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix |
| 03/03/2004 | CN1140510C Thermodynamically stable from of (R)-3[[(4-fluorophenyl)sulphonyl]amino]- 1,2,3,4-tetraydro-9H-carbazole-9-propanoic acid (ramatroban) |
| 03/03/2004 | CN1140508C Substed 4-biphenyl-4-hydroxybutyric acid derivs, and matrix metalloprotease inhibitors |
| 03/03/2004 | CN1140311C Blood processing system and mehtod which optically derive volume of platelets contained in plasma constituent |
| 03/03/2004 | CN1140295C Platelet-special chimeric immunoglobulin and method of use thereof |
| 03/03/2004 | CN1140292C Medicine for increasing leucocyte and its preparation method |
| 03/03/2004 | CN1140182C Coca components, edible products having enhanced polyphenol content, methods of making same and medical us |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699904 PPAR agonists |
| 03/02/2004 | US6699896 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 03/02/2004 | US6699888 Antiinflammatory |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 03/02/2004 | US6699871 Such as 7-((3r)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699857 Tetrahydroquinolinyl 6-methyldihydrothiadiazinone derivatives and use thereof |
| 03/02/2004 | US6699846 Such as ischemia and reperfusion injury, using specified glycolipids structurally related to monophosphoryl lipid a but with reduced proinflammatory and pyrogenic activity |
| 03/02/2004 | CA2196906C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 02/26/2004 | WO2004016807A1 Method for determining free thrombin concentration |
| 02/26/2004 | WO2004016607A1 Inhibition of phosphoinositide 3-kinase beta |
| 02/26/2004 | WO2004016267A1 Anticoagulant and fibrinolytic therapy using p38 map kinase inhibitors |
| 02/26/2004 | WO2004016264A1 Thrombopoetin receptor activator and process for producing the same |
| 02/26/2004 | WO2003106505A9 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 02/26/2004 | WO2003103584A3 Ether substituted imidazopyridines |
| 02/26/2004 | WO2003101374A3 Use of new etonogestrel esters |
| 02/26/2004 | WO2003088970A3 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/26/2004 | WO2003087333A3 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |